These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20042829)

  • 1. The effect of industry support on participants' perceptions of bias in continuing medical education.
    Kawczak S; Carey W; Lopez R; Jackman D
    Acad Med; 2010 Jan; 85(1):80-4. PubMed ID: 20042829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low rates of reporting commercial bias by physicians following online continuing medical education activities.
    Ellison JA; Hennekens CH; Wang J; Lundberg GD; Sulkes D
    Am J Med; 2009 Sep; 122(9):875-8. PubMed ID: 19699386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk stratification tool to assess commercial influences on continuing medical education.
    Barnes BE; Cole JG; King CT; Zukowski R; Allgier-Baker T; Rubio DM; Thorndyke LE
    J Contin Educ Health Prof; 2007; 27(4):234-40. PubMed ID: 18085603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of sponsored and unsponsored continuing medical education].
    Chon SH; Lösche P; Christ H; Lehmacher W; Griebenow R
    Med Klin (Munich); 2008 May; 103(5):341-5. PubMed ID: 18484220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey.
    Tabas JA; Boscardin C; Jacobsen DM; Steinman MA; Volberding PA; Baron RB
    Arch Intern Med; 2011 May; 171(9):840-6. PubMed ID: 21555662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commercial influence and learner-perceived bias in continuing medical education.
    Steinman MA; Boscardin CK; Aguayo L; Baron RB
    Acad Med; 2010 Jan; 85(1):74-9. PubMed ID: 20042828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The medical-industrial complex, professional medical associations, and continuing medical education.
    Schofferman J
    Pain Med; 2011 Dec; 12(12):1713-9. PubMed ID: 22145759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing an instrument to measure bias in CME.
    Takhar J; Dixon D; Donahue J; Marlow B; Campbell C; Silver I; Eadie J; Monette C; Rohan I; Sriharan A; Raymond K; Macnab J
    J Contin Educ Health Prof; 2007; 27(2):118-23. PubMed ID: 17576631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating conflicts of interest in research presented in CME venues.
    Davis NL; Galliher JM; Spano MS; Main DS; Brannigan M; Pace WD
    J Contin Educ Health Prof; 2008; 28(4):220-7. PubMed ID: 19058257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of commercial support on continuing pharmacy education.
    Smith JL; Cervero RM; Valentine T
    J Contin Educ Health Prof; 2006; 26(4):302-12. PubMed ID: 17163494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
    Rutledge P; Crookes D; McKinstry B; Maxwell SR
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercial support of continuing medical education in the United States: the politics of doubt, the value of studies.
    Mazmanian PE
    J Contin Educ Health Prof; 2009; 29(2):81-3. PubMed ID: 19530200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the value of CME: impact of an evidence-based CME credit designation on faculty and learners.
    Davis NL; Lawrence SL; Morzinski JA; Radjenovich ME
    Fam Med; 2009; 41(10):735-40. PubMed ID: 19882398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A standardized approach to assessing physician expectations and perceptions of continuing medical education.
    Shewchuk RM; Schmidt HJ; Benarous A; Bennett NL; Abdolrasulnia M; Casebeer LL
    J Contin Educ Health Prof; 2007; 27(3):173-82. PubMed ID: 17876846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
    Zoorob R; Larzelere M
    J La State Med Soc; 2004; 156(1):28-32. PubMed ID: 15000210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical education and communication companies: an updated in-depth profile.
    Golden GA; Parochka JN; Overstreet KM
    J Contin Educ Health Prof; 2002; 22(1):55-62. PubMed ID: 12004641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current guidelines regarding industry-sponsored continuing medical education.
    DelSignore JL
    Clin Orthop Relat Res; 2003 Jul; (412):21-7. PubMed ID: 12838047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attendees' perceptions of commercial influence in noncommercially funded CME programs.
    Goldfarb E; Baer L; Fromson JA; Gorrindo T; Iodice KE; Birnbaum RJ
    J Contin Educ Health Prof; 2012; 32(3):205-11. PubMed ID: 23008083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuing medical education and pharmaceutical industry.
    Vakani FS; Jafri W; Amin A; Sheerani M
    J Coll Physicians Surg Pak; 2011 Jun; 21(6):360-1. PubMed ID: 21711993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.